Diagnosis Related Group Costs in a Regulated Environment: A Note About Their Economic Interpretation

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.17, Iss.2, 2000-02, pp. : 115-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Economic Costs of Alcohol Abuse in Ontario

By Xie X. Rehm J. Single E. Robson L. Paul J.

Pharmacological Research, Vol. 37, Iss. 3, 1998-03 ,pp. : 241-249

Academic Press

Access to resources Recommend Favorite

Epidemiology and Costs of Hypertension-related Disorders

Current Pharmaceutical Design, Vol. 17, Iss. 28, 2011-09 ,pp. : 2955-2972

Bentham Science Publishers

Access to resources Recommend Favorite

Economic and Human Costs of Restless Legs Syndrome

By Reinhold Thomas Müller-Riemenschneider Falk Willich Stefan N. Brüggenjürgen Bernd

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 267-279

Adis International

Access to resources Recommend Favorite

Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations

By van Baal Pieter H.M. Wong Albert Slobbe Laurentius C.J.

PharmacoEconomics, Vol. 29, Iss. 3, 2011-03 ,pp. : 175-187

Adis International

Access to resources Recommend Favorite

Standardisation of Costs: The Dutch Manual for Costing in Economic Evaluations

By Oostenbrink J.B. Koopmanschap M.A. Rutten F.F.H.

PharmacoEconomics, Vol. 20, Iss. 7, 2002-01 ,pp. : 443-454

Adis International

Access to resources Recommend Favorite